Sarah S. Burns

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Obesity-induced inflammation exacerbates clonal hematopoiesis

Santhosh Kumar Pasupuleti, Baskar Ramdas, Sarah S. Burns et al. · Journal of Clinical Investigation · 2023 · 91 citations · Full text

AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas

Matthew L. Bush, Janet L. Oblinger, Victoria J Brendel et al. · Neuro-Oncology · 2011 · 77 citations · Full text

FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer

Gareth Griffiths, Sarah S. Burns, Simon Noble et al. · BMC Cancer · 2009 · 61 citations · Full text

Histone Deacetylase Inhibitor AR-42 Differentially Affects Cell-cycle Transit in Meningeal and Meningioma Cells, Potently Inhibiting <i>NF2</i> -Deficient Meningioma Growth

Sarah S. Burns, Elena M. Akhmametyeva, Janet L. Oblinger et al. · Cancer Research · 2012 · 59 citations